News Press Releases

Solera Health Adds DarioHealth to Its Cardiometabolic Network to Offer Hypertension Management Solutions

DRIO | June 15, 2022

The addition of Dario's hypertension solution expands Solera's suite of best-in-class digital and community evidence-based health solutions

PHOENIX, June 15, 2022 /PRNewswire/ -- Solera Health, the premier platform for connecting people seamlessly and easily to proven, personalized health solutions, announces its partnership with DarioHealth, a leading digital therapeutics company revolutionizing how people with chronic conditions manage their health through a user-centric platform. Together, Solera and DarioHealth are offering a turnkey, world class solution for treating hypertension, requiring just one contract and one technical integration to make this compelling new solution quickly available for payers' and employers' member populations.

Dario's hypertension solution offers access to a hyper-personalized experience that combines a Bluetooth or cellular-connected blood pressure monitor, a smart app that provides tracking, feedback and user specific content, and specially trained health coaches to provide one-on-one support. Unique program elements include rewards and gamification to maintain engagement and the ability to add blood glucose, weight, diet and activity data to provide a holistic view of a patient's health that users can easily share with a physician to align and improve health outcomes.

"Chronic conditions like hypertension can be difficult to manage, especially when in conjunction with multiple other diseases or symptoms," said Mary Langowski, CEO, Solera. "According to the CDC, nearly half of adults in the U.S. experience high blood pressure, and the prevalence increases with age. We are thrilled to expand Solera's offerings to patients with this condition through our partnership with Dario, as well as continue strengthening relationships with our health plan partners by empowering them to offer accessible, best-in-class digital health solutions."

Cardiometabolic conditions include both cardiovascular and metabolic diseases such as hypertension, obesity and diabetes. The addition of Solera's curated network of hypertension solutions allows users with these intersectional conditions to take a more comprehensive approach to managing their health.

Hypertension contributes up to $198 billion in healthcare costs annually and employee absenteeism related to hypertension costs employers more than $10 billion each year. By driving sustainable lifestyle modifications, ensuring medication adherence and offering accessible and continuous care, these digital solutions help address the gaps in hypertension care.

Dario provides patients with person-centric support through a combination of medical devices, smart technologies and mobile applications designed to engage, inspire and motivate users to make Dario a part of their daily journey towards healthy living. Dario's commitment to diversity, inclusion and health equity ensures consistent and continuous improvement in serving everyone with a chronic condition, and all communications through the platform are tailored to user preferences. With accessibility in mind, Dario offers tools and resources to help individuals manage and improve overall health based on their own lifestyles and symptoms.

"We are excited to partner with Solera and share our digital hypertension solutions with their payer and employer clients," said Rick Anderson, President & General Manager of North America of DarioHealth. "Dario is committed to improving access and quality of care for individuals with hypertension by expanding the reach of our highly personalized solutions. This collaboration with Solera expands our ability to reach patients and continue our mission of transforming care for people with chronic conditions."

Solera's extensive array of evidence-based solutions allows payers and employers to offer personalized, convenient health solutions by taking on the burden of administrative and resource-intensive tasks like claims processing, compliance, consumer engagement, eligibility checking, consumer matching and vendor management. This partnership adds hypertension to Solera's already expansive suite of condition offerings, including Mental & Behavioral Health, Musculoskeletal, Digestive Health, Weight Management, Diabetes Prevention & Management and Tobacco Cessation.

About Solera Health

Solera Health is committed to changing lives by guiding people seamlessly to better health solutions while providing payers and employers the tools to manage providers and outcomes across conditions. Solera's platform provides a marketplace of curated networks of digital and community point solutions focused on intensive, evidence-based lifestyle, behavioral and social interventions to impact the most prevalent and costly chronic conditions. Solera strategically matches consumers to their best-fit solution and helps keep them engaged for successful health outcomes. To learn more about Solera's partnerships and offerings, or how we can help member populations, contact us today at www.soleranetwork.com.

About DarioHealth Corp.

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do.

Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.

Media Contact:
Matt Maurel 512.387.3440
matt.maurel@anthonybarnum.com

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected timing of the contract launch and the potential benefits that may be realized by users utilizing the Dario platform. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.